Isolation and characterization of a relatively broad-spectrum phage against Escherichia coli
- 31 March 2024
- journal article
- research article
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (4) , 1-12
Abstract
Multiple pathogenic types or serotypes restrict treatment for colibacillosis. In addition, rising antibiotic resistance has heightened public awareness to prevent and control pathogenic Escherichia coli. The bacteriophage is a viable technique to treat colibacillosis as an alternative to antibiotics. In this study, PH444, a relatively broad-spectrum obligate lytic phage, was screened from 48 Shiga toxin-producing Escherichia coli (STEC) phages isolated from farm manure samples and sewage samples in order to conduct genome-wide analysis, biological characterization, and a bacterial challenge experiment in milk. The results demonstrated that PH444 was a T7-like phage with a double-stranded DNA of 115,111 bp that belongs to the Kuravirus and was stable at temperatures between 4 and 50 °C and a pH range of 3 to 11. After adding PH444, the bacterial load in milk could be reduced from 3 × 103 PFU/ mL to zero within 1 h. In consideration of the biological properties of phage PH444, it was, therefore, demonstrated that PH444 has the potential to be used in phage biocontrol.Keywords
Funding Information
- Natural Science Foundation of Anhui Province (2022AH052192, 2022AH052192)
- University-level science and technology team of Wuhu institute of technology (wzykjtd202002, wzykjtd202002)
- Natural Science Research Project of Anhui Province (KJ2021ZD0153, KJ2021ZD0153)
This publication has 29 references indexed in Scilit:
- Characterization and genomic analysis of a Demerecviridae phage SP76 with lytic multiple-serotypes of SalmonellaArchives of Microbiology, 2022
- Characterization and genome analysis of a broad lytic spectrum bacteriophage P479 against multidrug-resistant Escherichia coliVirus Research, 2022
- Overcoming barriers to phage application in food and feedCurrent Opinion in Biotechnology, 2020
- Non-O157 Shiga toxin-producing Escherichia coli—A poorly appreciated enteric pathogen: Systematic reviewInternational Journal of Infectious Diseases, 2018
- Application of bacteriophages in simultaneously controlling Escherichia coli O157:H7 and extended-spectrum beta-lactamase producing Escherichia coliApplied Microbiology and Biotechnology, 2018
- Associations Between Hydration Status, Intravenous Fluid Administration, and Outcomes of Patients Infected With Shiga Toxin–Producing Escherichia coliJAMA Pediatrics, 2017
- Developing and optimizing bacteriophage treatment to control enterohemorrhagic Escherichia coli on fresh produceInternational Journal of Food Microbiology, 2016
- Novel phage-based bio-processing of pathogenic Escherichia coli and its biofilmsWorld Journal of Microbiology and Biotechnology, 2011
- An Outbreak of Escherichia coli O157 Infection Following Exposure to a Contaminated BuildingJAMA, 2003
- Outbreaks of enterohaemorrhagic Escherichia colt O157:H7 infection by two different genotype strains in Japan, 1996The Lancet, 1996